Comparison of 225 actinium chelates:: Tissue distribution and radiotoxicity

被引:74
作者
Davis, IA
Glowienka, KA
Boll, RA
Deal, KA
Brechbiel, MW
Stabin, M
Bochsler, PN
Mirzadeh, S
Kennel, SJ
机构
[1] Oak Ridge Natl Lab, Div Life Sci, Oak Ridge, TN 37831 USA
[2] NCI, Radioimmune & Inorgan Chem Sect, ROB, DCS,NIH, Bethesda, MD 20892 USA
[3] IPEN CNEN SP, CN ENSP, Sao Paulo, Brazil
[4] Univ Tennessee, Coll Vet Med, Dept Pathol, Knoxville, TN USA
关键词
a-particle; biodistribution; radiotoxicity; tissue toxicity; biologic effective dose; chelators;
D O I
10.1016/S0969-8051(99)00024-4
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
The biodistribution and tissue toxicity of intravenously administered 225-actinium ((225)Ac) complexed with acetate, ethylene diamine tetraacetic acid (EDTA), 1, 4, 7, 10, 13-pentaazacyclopentadecane-N, N', N ", N''', N''''-pentaacetic acid (PEPA), or the "a" isomer of cyclohexyl diethylenetriamine pentaacetic acid (CHX-DTPA), were examined. The percent of injected dose per organ and per gram of tissue for each chelate complex was determined. (225)Ac-CHX-DTPA was evaluated further for radiotoxic effects. Mice receiving greater than or equal to 185 kBq (225)Ac-CHX-DTPA suffered 100% morbidity by 5 days and 100% mortality by 8 days postinjection, and all animals evaluated had significant organ damage. The in vivo instability of the (225)Ac-CHX-DTPA complex likely allowed accumulation of free (225)Ac in organs, which resulted in tissue (C) 1999 Elsevier Science Inc. All rights reserved. pathology.
引用
收藏
页码:581 / 589
页数:9
相关论文
共 25 条
[1]  
ATKINS TJ, ORG SYNTH, V6, P652
[2]  
Beyer G. J., 1995, Journal of Labelled Compounds and Radiopharmaceuticals, V37, P529
[3]   COMPARISON OF THE BIODISTRIBUTION OF AC-225 AND RADIOLANTHANIDES AS CITRATE COMPLEXES [J].
BEYER, GJ ;
BERGMANN, R ;
SCHOMACKER, K ;
ROSCH, F ;
SCHAFER, G ;
KULIKOV, EV ;
NOVGORODOV, AF .
ISOTOPENPRAXIS, 1990, 26 (03) :111-114
[4]  
Boll RA, 1997, RADIOCHIM ACTA, V79, P145
[5]  
DURBIN PATRICIA W., 1960, HEALTH PHYS, V2, P225
[6]  
ELSAMAD O, 1993, RADIOCHIM ACTA, V62, P65
[7]   THE FEASIBILITY OF AC-225 AS A SOURCE OF ALPHA-PARTICLES IN RADIOIMMUNOTHERAPY [J].
GEERLINGS, MW ;
KASPERSEN, FM ;
APOSTOLIDIS, C ;
VANDERHOUT, R .
NUCLEAR MEDICINE COMMUNICATIONS, 1993, 14 (02) :121-125
[8]  
HARKNESS JE, 1983, BIOL MED RABBITS ROD, P38
[9]  
HUGHES BJ, 1989, CANCER RES, V49, P6214
[10]  
KELLER HK, 1981, GMELIN HDB INORGANIC, P230